1. Wallonia, the place to innovate in health First China-Belgium Innovation Dialogue March 30, Laurence Timmermans BioWin

2. Wallonia, the place to innovate in health
The biopharmaceutical industry is the driving force for growth in the region.
It is the main industrial activity in Wallonia in terms of added value; it provides 54% of jobs in the Belgian pharmaceutical sector.
Turn over (2015): Euros 5.4 billion
Direct jobs (2015): 16,960 (+ 32,000 indirect jobs)
Private R&D investments (2015) : Euros 1.2 billion
Cumulated private capital raised by SMEs ( ) : Euros 1,150 billion
Pharma/Biopharma = 25% of total Wallonia export
Average annual employment growth rate since 2006
7,3% - large, medium, small companies combined
12,8% - small & medium companies

3. Our members 157 innovative SMEs University hospitals with 20 000 beds
researchers
7 global leaders
400 research units from 5 universities with many research centres
Non exhaustive

4. Key FIGURES - BIOWIN MEMBERS
164 BioWin members classified by technology

5. SMART SPECIALISATION STRATEGY

6. BIOWIN’S core activities
43 R&D projects
246 partners
EUR 138 million
Wal-Dx/EDCA
Rad4Med.be
Bilateral collaborative agreements (Canada, Massachusetts USA, Alsace France)
17 training projects (EUR M29,6)
people trained
One-stop shopping platform
Cell therapy
Proton therapy
Big data
Biobanking network

7. JUKE Biotech Park (Shanghai)
With the support of:
Boston
Shanghai
Europe P
JUKE Biotech Park (Shanghai) N
Guanzhou
international PARTNERSHIPS

8. Head of international affairs
XIE XIE 谢谢 Thank you
Your contact at BioWin
Laurence TIMMERMANS
Head of international affairs
BioWin Maison de l’Industrie Rue Auguste Piccard, 20
6041 Gosselies – Belgium
Tel.: +32 (0) E: